Overview

Clinical Study of Anti-CD147 Humanized Meplazumab for Injection to Treat With 2019-nCoV Pneumonia

Status:
Completed
Trial end date:
2020-03-09
Target enrollment:
Participant gender:
Summary
To evaluate the safety and efficacy of humanized Meplazumab for Injection in patients infected by 2019-nCoA.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Tang-Du Hospital